Jianying Zhou Selected Research

aumolertinib

1/2022	AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
1/2022	Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianying Zhou Research Topics

Disease

54	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2002
41	Neoplasms (Cancer) 04/2022 - 03/2009
19	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2009
13	Disease Progression 10/2022 - 08/2011
13	Adenocarcinoma of Lung 01/2022 - 06/2009
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
8	Diarrhea 01/2022 - 07/2014
8	Exanthema (Rash) 01/2022 - 09/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
6	Asthma (Bronchial Asthma) 01/2021 - 07/2010
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2015
5	Infections 10/2020 - 05/2016
4	COVID-19 01/2021 - 01/2020
3	Adenocarcinoma 01/2022 - 01/2021
3	Carcinoma (Carcinomatosis) 10/2021 - 09/2015
3	Pulmonary Aspergillosis 01/2021 - 04/2018
3	Brain Neoplasms (Brain Tumor) 12/2020 - 06/2015
3	Pleural Effusion (Pleural Effusions) 01/2017 - 01/2015
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2017
2	Atrophy 01/2022 - 06/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2022 - 06/2020
2	Lymphatic Metastasis 01/2022 - 09/2016
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2018
2	Thalassemia 10/2021 - 01/2020
2	Sepsis (Septicemia) 02/2021 - 02/2016
2	Bacteremia 02/2021 - 03/2019
2	Neutropenia 01/2021 - 10/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2019
2	Nausea 01/2021 - 12/2020
2	Vision Disorders (Hemeralopia) 01/2021 - 10/2018
2	Leukopenia 01/2021 - 10/2018
2	Vomiting 01/2021 - 12/2020
2	Critical Illness (Critically Ill) 05/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Fever (Fevers) 01/2020 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2019 - 01/2019
2	Lung Diseases (Lung Disease) 01/2019 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 02/2012
2	Malignant Pleural Effusion 01/2017 - 06/2015
2	Inflammation (Inflammations) 01/2017 - 11/2012
2	Respiratory Hypersensitivity 01/2017 - 11/2012

Drug/Important Bio-Agent (IBA)

20	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2010
11	CrizotinibIBA 11/2021 - 01/2015
10	Proteins (Proteins, Gene)FDA Link 04/2021 - 04/2002
10	Anaplastic Lymphoma KinaseIBA 12/2020 - 01/2014
9	Tyrosine Kinase InhibitorsIBA 01/2022 - 08/2011
8	CytokinesIBA 01/2022 - 03/2009
8	Gefitinib (Iressa)FDA Link 01/2022 - 09/2013
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2017
7	icotinibIBA 01/2021 - 08/2011
6	Pemetrexed (MTA)FDA Link 01/2021 - 10/2012
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2010
5	LigandsIBA 04/2021 - 03/2009
5	PlatinumIBA 01/2021 - 08/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2020
4	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2019
4	B7-H1 AntigenIBA 05/2021 - 09/2017
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
4	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2015
3	deguelinIBA 01/2022 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
3	p38 Mitogen-Activated Protein KinasesIBA 11/2021 - 03/2016
3	Bevacizumab (Avastin)FDA Link 02/2021 - 12/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2011
3	NivolumabIBA 01/2021 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2011
3	Transaminases (Aminotransferases)IBA 10/2018 - 07/2014
2	Docetaxel (Taxotere)FDA Link 03/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 03/2009
2	aumolertinibIBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2019
2	Biological ProductsIBA 01/2022 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 07/2010
2	AntigensIBA 03/2021 - 05/2019
2	Carbapenems (Carbapenem Antibiotics)IBA 02/2021 - 03/2019
2	Lopinavir FDA Link 01/2021 - 01/2020
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 06/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2019
2	Ritonavir (Norvir)FDA Link 01/2021 - 01/2020
2	sintilimabIBA 01/2021 - 01/2021
2	Voriconazole (Vfend)FDA LinkGeneric 01/2021 - 01/2021
2	ceritinibIBA 12/2020 - 04/2017
2	Adenosine Monophosphate (AMP)IBA 12/2020 - 03/2014
2	Moxifloxacin (Avelox)FDA Link 10/2020 - 01/2015
2	Antiviral Agents (Antivirals)IBA 05/2020 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020 - 01/2015
2	dioscinIBA 01/2020 - 01/2020
2	HMPL-013IBA 01/2020 - 01/2018
2	SteroidsIBA 01/2020 - 02/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 03/2009
2	Immunoglobulin M (IgM)IBA 11/2018 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2015
2	anlotinibIBA 01/2018 - 01/2018

Therapy/Procedure

32	Therapeutics 10/2022 - 07/2011
29	Drug Therapy (Chemotherapy) 03/2022 - 06/2011
8	Immunotherapy 04/2021 - 03/2009
2	Artificial Respiration (Mechanical Ventilation) 06/2020 - 01/2020